Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam
11:07am, Thursday, 14'th May 2026
AxoGen NASDAQ: AXGN President and CEO Michael Dale said the company's growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expecte
Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
06:00pm, Wednesday, 13'th May 2026
Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
07:00am, Thursday, 30'th Apr 2026
ALACHUA, Fla. and TAMPA, Fla.
Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript
05:41pm, Tuesday, 28'th Apr 2026
Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript
AxoGen (AXGN) Q1 Earnings Lag Estimates
09:16am, Tuesday, 28'th Apr 2026
AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.
Axogen, Inc. Reports First Quarter 2026 Financial Results
07:00am, Tuesday, 28'th Apr 2026
ALACHUA, Fla. and TAMPA, Fla.
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
10:38am, Sunday, 26'th Apr 2026
This healthcare firm develops nerve repair solutions for hospitals and specialists in the U.S. and select global markets.
AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 21'st Apr 2026
AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AxoGen (AXGN) Surges 7.5%: Is This an Indication of Further Gains?
08:00am, Friday, 17'th Apr 2026
AxoGen (AXGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
07:00am, Tuesday, 14'th Apr 2026
ALACHUA, Fla. and TAMPA, Fla.
SG Americas Securities LLC Increases Stock Holdings in AxoGen, Inc. $AXGN
04:45am, Sunday, 05'th Apr 2026
SG Americas Securities LLC boosted its position in AxoGen, Inc. (NASDAQ: AXGN) by 459.9% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6
AxoGen, Inc. $AXGN Shares Sold by JPMorgan Chase & Co.
04:57am, Saturday, 04'th Apr 2026
JPMorgan Chase and Co. cut its holdings in shares of AxoGen, Inc. (NASDAQ: AXGN) by 44.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fun
Exchange Traded Concepts LLC Sells 26,743 Shares of AxoGen, Inc. $AXGN
03:52am, Saturday, 04'th Apr 2026
Exchange Traded Concepts LLC lowered its stake in AxoGen, Inc. (NASDAQ: AXGN) by 45.6% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exc
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know
02:59pm, Tuesday, 24'th Mar 2026
An Axogen executie reported selling 5,221 shares of Common Stock for a transaction value of approximately $171,000 on March 16, 2026. This represented 1.95% of total holdings as reported in the Form 4
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
07:53pm, Saturday, 21'st Mar 2026
DAFNA Capital Management sold 265,456 AXGN shares in the fourth quarter, with an estimated transaction value of $6.53 million based on quarterly average prices. Meanwhile, the quarter-end position val
